AKT1 and colorectal carcinoma: It was reported that the cooccurrence of alterations in the Ras/MAPK and PI3K/AKT pathways are common in CRC, which suggested that the simultaneous inhibition of the Ras/MAPK and PI3K/AKT pathways might be beneficial in the treatment of CRC.30